stockrowAccuray Incorporated (ARAY) vs Cytosorbents Corporation (CTSO)
- Accuray Incorporated ARAY 0.11 −8.33%
- Cytosorbents Corporation CTSO 4.75 +3.26%
Accuray Incorporated and Cytosorbents Corporation are both Medical Devices companies. Accuray Incorporated and Cytosorbents Corporation are of similar size ($14.8M and $14.5M). Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −12.5%. Accuray Incorporated has the higher net margin (−4.41% vs −48.9%) and the higher return on invested capital (−21.8% vs −66.9%). Across the 17 metrics below, Accuray Incorporated leads on 11 and Cytosorbents Corporation on 6.
Valuation
Profitability
| Metric | ARAY | CTSO | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 71.61% | 57.76% |
| Operating margin | (13.09%) | (34.74%) | (14.84%) |
| Net margin | (4.41%) | (48.94%) | (14.45%) |
| Free cash flow margin | (6.86%) | (25.32%) | (5.70%) |
| Return on equity | (30.23%) | (336.17%) | (10.56%) |
| Return on assets | (4.10%) | (42.38%) | (17.26%) |
| Return on invested capital | (21.79%) | (66.90%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack